Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 250 results in range #251 to #500.
- AA battery (1 revision)
- ACOT1 (1 revision)
- ARHGAP31 (1 revision)
- Ф29 phage (1 revision)
- ACOT11 (1 revision)
- ACOT7 (1 revision)
- ACSBG1 (1 revision)
- ACRRM (1 revision)
- ACTL8 (1 revision)
- ACSBG2 (1 revision)
- ACOT4 (1 revision)
- ACSF3 (1 revision)
- ACSM2B (1 revision)
- ACS National Historical Chemical Landmarks (1 revision)
- ACSS3 (1 revision)
- ACTR2 (1 revision)
- A-box 1 of insulin gene (1 revision)
- ACTL7A (1 revision)
- ABCB11 (1 revision)
- ACVR1C (1 revision)
- ACTN1 (1 revision)
- A1CF (1 revision)
- ACTR3 (1 revision)
- ADAMTS4 (1 revision)
- ACTN3 (gene) (1 revision)
- ACTR3B (1 revision)
- 5-Lipoxygenase activating protein (1 revision)
- AD-mix (1 revision)
- 5-alpha-reductase deficiency cost-effectiveness of therapy (1 revision)
- AM-855 (1 revision)
- ADK (gene) (1 revision)
- 8-Aminoquinoline (1 revision)
- AGBL4 (1 revision)
- AFF3 (1 revision)
- ACVR1B (1 revision)
- ADAM18 (1 revision)
- ABCC12 (1 revision)
- 5-MeO-DALT (1 revision)
- 5-Formamidoimidazole-4-carboxamide ribotide (1 revision)
- ADAM28 (1 revision)
- 5-alpha-reductase deficiency future or investigational therapies (1 revision)
- 60S ribosomal protein L10-like (1 revision)
- ADAM15 (1 revision)
- AD-36 (1 revision)
- AP2M1 (1 revision)
- 5-alpha-reductase deficiency electrocardiogram (1 revision)
- 5-Methylcytosine (1 revision)
- 5-Hydroxytryptophan (1 revision)
- ADAMTS9 (1 revision)
- APOL6 (1 revision)
- 5-Methyltetrahydrofolate (1 revision)
- 72F fusion protein (1 revision)
- ADAMTS12 (1 revision)
- 5-MeS-DMT (1 revision)
- AAA1 (1 revision)
- AAAS (gene) (1 revision)
- 22q11.2 deletion syndrome case study one (1 revision)
- AEGIS II Visit Scheduler (test mode) (1 revision)
- AADAC (1 revision)
- 60S ribosomal protein L37 (1 revision)
- ADAMTSL1 (1 revision)
- ADFP (1 revision)
- AADACL3 (1 revision)
- 22q11.2 deletion syndrome echocardiography or ultrasound (1 revision)
- AADACL4 (1 revision)
- AGPAT9 (1 revision)
- ADCY10 (1 revision)
- 5-Methylindole (1 revision)
- ABI1 (1 revision)
- ADM2 (1 revision)
- 60S ribosomal protein L30 (1 revision)
- 60S ribosomal protein L19 (1 revision)
- AFM (gene) (1 revision)
- ADNP (gene) (1 revision)
- ADAMTS8 (1 revision)
- 5-hydroxytryptophan (1 revision)
- ACOT6 (1 revision)
- ALPK1 (1 revision)
- 60S ribosomal protein L9 (1 revision)
- 60S ribosomal protein L8 (1 revision)
- AAK (1 revision)
- ABCA10 (1 revision)
- AGPAT3 (1 revision)
- 23andMe (1 revision)
- 24-Dehydrocholesterol reductase (1 revision)
- AICDA (1 revision)
- AGXT2 (1 revision)
- 2C-B (1 revision)
- 2C-B-BZP (1 revision)
- 2C-B-FLY (1 revision)
- AIF1 (1 revision)
- 2C-D (1 revision)
- AIDA interactive educational freeware diabetes simulator (1 revision)
- AIR synthetase (FGAM cyclase) (1 revision)
- AKAP (1 revision)
- AIP (gene) (1 revision)
- 2C-I (1 revision)
- AKAP7 (1 revision)
- AKAP2 (1 revision)
- AKR1A1 (1 revision)
- AKIRIN2 (1 revision)
- ALARA (1 revision)
- ALDH16A1 (1 revision)
- ALD-52 (1 revision)
- AKR7A3 (1 revision)
- ALDH1B1 (1 revision)
- ALDH3B1 (1 revision)
- ALDH3A1 (1 revision)
- ALDH1A3 (1 revision)
- 2C-T-7 (1 revision)
- ALDH5A1 (gene) (1 revision)
- ALDH4A1 (1 revision)
- 2C-TFM (1 revision)
- ALDOC (1 revision)
- 2R hypothesis (1 revision)
- 2b3a (1 revision)
- 2nd Skin (1 revision)
- AKR1C4 (1 revision)
- 2α-(Propanoyl)-3β-(2-(6-methoxynaphthyl))-tropane (1 revision)
- 2β-propanoyl-3β-(2-naphthyl)-tropane (1 revision)
- 2β-propanoyl-3β-(4-tolyl)-tropane (1 revision)
- ALIVE (1 revision)
- ALG12 (1 revision)
- ALPHA (psychedelic) (1 revision)
- ALLHAT trial (1 revision)
- 3,4-Diaminopyridine (1 revision)
- 3,4-Dimethylamphetamine (1 revision)
- ALS Therapy Development Institute (1 revision)
- ABT-239 (1 revision)
- 3-Aminoisobutyric acid (1 revision)
- 3-Aminopyridine (1 revision)
- ALX1 (1 revision)
- 3-Hydroxyacyl ACP dehydrase (1 revision)
- AM-906 (1 revision)
- ACACB (1 revision)
- 3-Methylcrotonyl-CoA carboxylase deficiency (1 revision)
- AM-919 (1 revision)
- ABTB1 (1 revision)
- 3-Methylglutaconyl CoA (1 revision)
- AM251 (1 revision)
- 3-Quinuclidinyl benzilate (1 revision)
- 3-Ureidopropionic acid (1 revision)
- 3-dehydrosphinganine reductase (1 revision)
- AMBN (1 revision)
- 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (1 revision)
- AMG-3 (1 revision)
- AMPA receptor (1 revision)
- 3-hydroxyacyl-coenzyme A dehydrogenase deficiency (1 revision)
- 3-hydroxyisobutyrate dehydrogenase (1 revision)
- ANKRD31 (1 revision)
- 3-methylglutaconic acid (1 revision)
- 310 helix (1 revision)
- AMG-36 (1 revision)
- AMG-41 (1 revision)
- 3C-P (1 revision)
- AMOT (1 revision)
- 3T3-L1 (1 revision)
- 5-HT receptor (1 revision)
- 3 beta-hydroxysteroid dehydrogenase deficiency historical perspective (1 revision)
- 3 hydroxyisobutyric aciduria (1 revision)
- 3 methylcrotonic aciduria (1 revision)
- 3c syndrome (1 revision)
- 3m syndrome (1 revision)
- ANKFY1 (1 revision)
- 3β-(4'-chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)tropane (1 revision)
- ANKK1 (1 revision)
- 4,5-MDO-DMT (1 revision)
- 4,5-MDO-DiPT (1 revision)
- ACAT2 (1 revision)
- AP1G1 (1 revision)
- 4-Acetoxy-DET (1 revision)
- 4-Acetoxy-DIPT (1 revision)
- ANKRD26 (1 revision)
- 4-Aminobiphenyl (1 revision)
- ACBD3 (1 revision)
- 4-Aminoquinoline (1 revision)
- 4-Androstene-3,6,17-trione (1 revision)
- ANXA11 (1 revision)
- AANAT (gene) (1 revision)
- ANXA7 (1 revision)
- 4-Chloroindole-3-acetic acid (1 revision)
- AO/OTA classification for the distal tibial Fracture (1 revision)
- 4-Dimethylaminophenol (1 revision)
- 4-HO-DBT (1 revision)
- 4-HO-DET (1 revision)
- 4-HO-DPT (1 revision)
- 4-HO-DiPT (1 revision)
- 4-HO-MET (1 revision)
- 4-HO-MPT (1 revision)
- 4-HO-pyr-T (1 revision)
- 4-Hydroxy-4-methylpentanoic acid (1 revision)
- AP1M1 (1 revision)
- AP1GBP1 (1 revision)
- 4-Hydroxytestosterone (1 revision)
- 4-MTA (1 revision)
- 4-MeO-MiPT (1 revision)
- 4-Methylbenzylidene camphor (1 revision)
- AP4M1 (1 revision)
- 4-Methylthioamphetamine (1 revision)
- 4-Nitroaniline (1 revision)
- APBA3 (1 revision)
- 4-Oxalocrotonate tautomerase (1 revision)
- ACCN3 (1 revision)
- AASDHPPT (1 revision)
- 40S (1 revision)
- APC (1 revision)
- 40S ribosomal protein S11 (1 revision)
- 40S ribosomal protein S12 (1 revision)
- 40S ribosomal protein S13 (1 revision)
- 40S ribosomal protein S14 (1 revision)
- 40S ribosomal protein S15a (1 revision)
- APBB1IP (1 revision)
- 40S ribosomal protein S18 (1 revision)
- 40S ribosomal protein S19 (1 revision)
- ACER3 (1 revision)
- ACER2 (1 revision)
- ACER1 (1 revision)
- 40S ribosomal protein S23 (1 revision)
- 40S ribosomal protein S24 (1 revision)
- APIP (1 revision)
- 40S ribosomal protein S26 (1 revision)
- APOBEC3D (1 revision)
- 40S ribosomal protein S28 (1 revision)
- ACES (nutritional supplement) (1 revision)
- 40S ribosomal protein S3 (1 revision)
- ACF (gene) (1 revision)
- 40S ribosomal protein S4, Y isoform 1 (1 revision)
- 40S ribosomal protein S4, Y isoform 2 (1 revision)
- 40S ribosomal protein S5 (1 revision)
- 40S ribosomal protein S7 (1 revision)
- 40S ribosomal protein S8 (1 revision)
- 40S ribosomal protein S9 (1 revision)
- 454 Life Sciences (1 revision)
- ADAM17 (1 revision)
- 7-Dehydrocholesterol reductase (1 revision)
- 999 (emergency telephone number) (1 revision)
- AP4E1 (1 revision)
- 9q34 deletion syndrome (1 revision)
- 5'-3' exoribonuclease 1 (1 revision)
- ARB Project (1 revision)
- ARHGAP27 (1 revision)
- 5'-Phosphoribosylformylglycinamidine (1 revision)
- 5'-phosphoribosyl-4-carboxy-5-aminoimidazole (1 revision)
- 5'-phosphoribosyl-5-aminoimidazole (1 revision)
- 5' flanking region (1 revision)
- 5,10-Methylenetetrahydrofolate (1 revision)
- 5,6-MDO-DMT (1 revision)
- 5,6-MDO-DiPT (1 revision)
- 5,6-MDO-MiPT (1 revision)
- 5,6-MeO-MiPT (1 revision)